The adipokine functions of nesfatin-1: Its effects on adipose tissue physiology and metabolic diseases
Open Access
- 9 February 2026
- journal article
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 8 (2) , 1-12
Abstract
Nesfatin-1, a pleiotropic peptide derived from the nucleobindin-2 precursor, exhibits widespread distribution in the central nervous system and peripheral tissues. It plays a critical role in regulating energy homeostasis. Its high concentration in the appetite control centers of the hypothalamus indicates that Nesfatin-1 is a potent anorexigenic peptide, which suppresses food intake through melanocortin-dependent but leptin-independent mechanisms. Its capacity to augment insulin secretion and regulate glucose metabolism by activating L-type calcium channels in pancreatic β-cells renders Nesfatin-1 a promising therapeutic target, particularly for type 2 diabetes. Nesfatin-1 has also been shown to be active in hypothalamic and limbic circuits associated with stress, anxiety, and behavioral responses. Levels of Nesfatin-1 exhibit fluctuations in response to acute and chronic stress conditions. Nesfatin-1 has been reported to increase arterial pressure via central oxytocinergic and melanocortinergic pathways in the cardiovascular system. At the peripheral level, it produces vasoconstrictive effects via eNOS inhibition. Although Nesfatin-1 has been demonstrated to possess anti-inflammatory and anti-apoptotic properties in experimental models, the findings from clinical studies are heterogeneous, and its potential as a biomarker remains uncertain. In summary, Nesfatin-1 is a significant molecule that has the potential to contribute to the development of novel treatment strategies for obesity, diabetes, neuropsychiatric disorders, and inflammatory processes. However, it is imperative to define its mechanisms with precision.Keywords
This publication has 42 references indexed in Scilit:
- Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disordersMolecular Metabolism, 2022
- Nesfatin-1 – as a diagnosis regulatory peptide in type 2 diabetes mellitusJournal of Diabetes & Metabolic Disorders, 2022
- Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndromeSleep and Breathing, 2014
- Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndromeJournal of Endocrinological Investigation, 2014
- Nesfatin-1 induces Fos expression and elicits dipsogenic responses in subfornical organBehavioural Brain Research, 2013
- Nesfatin-1 and other hormone alterations in polycystic ovary syndromeEndocrine, 2012
- A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in ratsBiochemical and Biophysical Research Communications, 2012
- Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjectsCell and tissue research, 2011
- Restraint stress activates nesfatin-1-immunoreactive brain nuclei in ratsBrain Research, 2009
- To be or NUCB2, is nesfatin the answer?Cell Metabolism, 2006